Viral-specific T-lymphocytes
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Viral-specific T-lymphocytes, covering 2024-05-06 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity [Phase 1, Phase 2]